Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 2
2001 1
2003 2
2004 1
2005 2
2007 1
2008 3
2009 4
2010 2
2011 5
2012 6
2013 12
2014 8
2015 15
2016 9
2017 22
2018 29
2019 22
2020 21
2021 23
2022 24
2023 16

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Results by year

Filters applied: . Clear all
Page 1
Oral agents in multiple sclerosis.
Lorefice L, Fenu G, Frau J, Coghe GC, Marrosu MG, Cocco E. Lorefice L, et al. Among authors: frau j. Antiinflamm Antiallergy Agents Med Chem. 2015;14(1):15-25. doi: 10.2174/1871523014999150415130224. Antiinflamm Antiallergy Agents Med Chem. 2015. PMID: 25924620 Review.
FT-IR study of pyridoxamine 5' phosphate.
Salvà A, Frau J, Muñoz F, Vilanova B, Donoso J. Salvà A, et al. Among authors: frau j. Biochim Biophys Acta. 2003 Apr 11;1647(1-2):83-7. doi: 10.1016/s1570-9639(03)00061-x. Biochim Biophys Acta. 2003. PMID: 12686113 Review.
Monoclonal antibodies: a target therapy for multiple sclerosis.
Lorefice L, Fenu G, Frau J, Coghe G, Marrosu MG. Lorefice L, et al. Among authors: frau j. Inflamm Allergy Drug Targets. 2014;13(2):134-43. doi: 10.2174/1871528113666140513114815. Inflamm Allergy Drug Targets. 2014. PMID: 24479836 Review.
200 results